SB 202190

Catalog # Availability Size / Price Qty
1264/10
1264/50
SB 202190 | CAS No. 152121-30-7 | p38 Inhibitors
1 Image
Description: Potent, selective inhibitor of p38 MAPK

Chemical Name: 4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol

Product Details
Citations (36)
Reviews (3)

Biological Activity

A highly selective, potent and cell-permeable inhibitor of p38 MAP kinase. Binds within the ATP pocket of the active kinase (Kd = 38 nM, as measured in recombinant human p38), and selectively inhibits the p38α and β isoforms (IC50 = 50 and 100 nM at SAPK2a/p38 and SAPK2b/p38β2 respectively). Promotes stability of naive human pluripotent stem cells in culture. Also available as part of the MAPK Inhibitor Tocriset™.

Technical Data

Formula:
C20H14N3OF
Solubility:
Soluble to 100 mM in DMSO
Storage:
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
CAS No:
152121-30-7

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Additional Information

Licensing Caveats:
Sold with the permission of GlaxoSmithKline

Product Datasheets

or select another batch:
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Citations for SB 202190

The citations listed below are publications that use Tocris products. Selected citations for SB 202190 include:

36 Citations: Showing 1 - 10

  1. Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model.
    Authors: Ranganathan Et al.
    Infect Immun  2019;87
  2. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
    Authors: Schiff Et al.
    Commun Biol  2019;2:162
  3. Improving Cell Survival in Injected Embryos Allows Primed Pluripotent Stem Cells to Generate Chimeric Cynomolgus Monkeys.
    Authors: Kang Et al.
    Cell Rep  2018;25:2563
  4. IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression.
    Authors: Nadeem
    Cytokine  2017;97:14
  5. Type I and Type III IF.s Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.
    Authors: Pervolaraki Et al.
    Front Immunol  2017;8:459
  6. TNFα induces tolerant production of CXC chemokines in colorectal cancer HCT116 cells via A20 inhibition of ERK signaling.
    Authors: Zhou
    Int Immunopharmacol  2017;54(296)
  7. p38 MAPK as an essential regulator of dorsal-ventral axis specification and skeletogenesis during sea urchin development: a re-evaluation.
    Authors: Molina Et al.
    Development  2017;144:2270
  8. Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK.
    Authors: Wong Et al.
    J Neuroinflammation  2016;13:251
  9. Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis.
    Authors: Tichet Et al.
    Nat Commun  2015;6:6993
  10. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.
    Authors: Page Et al.
    Biomaterials  2015;64:33
  11. Excess salt exacerbates blood-brain barrier disruption via a p38/MAPK/SGK1-dependent pathway in permanent cerebral ischemia.
    Authors: Zhang Et al.
    PLoS One  2015;5:16548
  12. The role of Na+/K+-ATPase during chick skeletal myogenesis.
    Authors: Oliveira Et al.
    J Neurosci  2015;10:e0120940
  13. Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK.
    Authors: Toutounchian Et al.
    PLoS One  2014;9:e100210
  14. TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells.
    Authors: Babu Et al.
    BMC Cancer  2014;14:113
  15. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.
    Authors: Kleinewietfeld Et al.
    Sci Rep  2013;496:518
  16. 3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells.
    Authors: Nicastro Et al.
    J Nutr Biochem  2013;24:1882
  17. Identification of repurposed small molecule drugs for chordoma therapy.
    Authors: Xia Et al.
    Cancer Biol Ther  2013;14:638
  18. Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family.
    Authors: Morse Et al.
    BMC Pharmacol Toxicol  2013;14:17
  19. Post-transcriptional regulation of placenta growth factor mRNA by hydrogen peroxide.
    Authors: Shaw and Lloyd
    Nature  2012;84:155
  20. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis.
    Authors: Akhmetshina Et al.
    J Biol Chem  2012;3:735
  21. BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells.
    Authors: Zhu Et al.
    Am J Physiol Lung Cell Mol Physiol  2012;31:31
  22. A screen for regulators of survival of motor neuron protein levels.
    Authors: Makhortova Et al.
    Nat Chem Biol  2011;7:544
  23. Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target.
    Authors: Morse Et al.
    PLoS One  2011;6:e25643
  24. Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling.
    Authors: Medici Et al.
    J Exp Clin Cancer Res  2011;437:515
  25. Dermatophagoides pteronyssinus 2 regulates nerve growth factor release to induce airway inflammation via a reactive oxygen species-dependent pathway.
    Authors: Ye Et al.
    Am J Physiol Regul Integr Comp Physiol  2011;300:L216
  26. Dual specificity phosphatase 1 regulates human inducible nitric oxide synthase expression by p38 MAP kinase.
    Authors: Turpeinen Et al.
    J Neurosci  2011;2011:127587
  27. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension.
    Authors: Wong Et al.
    Circ Res  2010;107:984
  28. Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.
    Authors: Riedl Et al.
    Nat Commun  2009;29:13377
  29. PLZF is a regulator of homeostatic and cytokine-induced myeloid development.
    Authors: Doulatov Et al.
    Genes Dev  2009;23:2076
  30. Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA.
    Authors: Guillemot and Citi
    Mol Biol Cell  2006;17:3569
  31. Temporally and spatially coordinated roles for Rho, Rac, Cdc42 and their effectors in growth cone guidance by a physiological electric field.
    Authors: Rajnicek Et al.
    J Cell Sci  2006;119:1723
  32. Oxygen-sensitive {δ}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection.
    Authors: Ma Et al.
    Mediators Inflamm  2005;280:16208
  33. Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia.
    Authors: Bellik Et al.
    Br J Pharmacol  2005;146:568
  34. Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1.
    Authors: Gallagher Et al.
    Biochem J  2004;24:4859
  35. Calcineurin-independent inhibition of mitochondrial Ca2+ uptake by cyclosporin A.
    Authors: Montero Et al.
    Br J Pharmacol  2004;141:263
  36. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation.
    Authors: Atherton Et al.
    Am J Physiol Lung Cell Mol Physiol  2003;285:L730

FAQs

No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Reviews for SB 202190

Average Rating: 3.3 (Based on 3 Reviews)

5 Star
0%
4 Star
33.33%
3 Star
66.67%
2 Star
0%
1 Star
0%

Have you used SB 202190?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Easy to store and use
By Anonymous on 02/07/2019
Species: Human

I used this to test the potency of this to kill of COLO 205 cells with the addition of TNF in a dose dependent manner.


Works, but don't store 6 months greater
By Scott Scarneo on 02/06/2019
Species: Human

Stored ok, seemed to lose potency over time at -20 aliquots.


Good inhibitor for cell studies
By Anonymous on 12/26/2018
Species: Human

I compared this inhibitor to a TAK1 inhibitor to compared effects on cell death.


Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.